We are live on
!
Find out more
SC
Samlyn Capital Portfolio holdings
AUM
$5.86B
1-Year Est. Return
36.3%
This Fund
S&P 500
This Quarter
Est. Return
+11.19%
1 Year Est. Return
+36.3%
3 Year Est. Return
+115.4%
5 Year Est. Return
+175.71%
10 Year Est. Return
+881.8%
AUM
$6.82B
AUM Growth
-$426M
(-5.9%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-15.86%
Top 10 Holdings %
Top 10 Hldgs %
37.78%
Holding
211
New
63
Increased
45
Reduced
53
Closed
48
Top Buys
| 1 |
Biogen
BIIB
|
+$114M |
| 2 |
KKR & Co
KKR
|
+$113M |
| 3 |
Walt Disney
DIS
|
+$93.6M |
| 4 |
MetLife
MET
|
+$83.2M |
| 5 |
GFL Environmental
GFL
|
+$57.8M |
Top Sells
| 1 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$236M |
| 2 |
Target
TGT
|
+$191M |
| 3 |
Morgan Stanley
MS
|
+$174M |
| 4 |
Interactive Brokers
IBKR
|
+$111M |
| 5 |
Uber
UBER
|
+$107M |
Sector Composition
| 1 | Financials | 26.62% |
| 2 | Consumer Discretionary | 20.17% |
| 3 | Healthcare | 13.24% |
| 4 | Communication Services | 12.31% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
76
Bicycle Therapeutics
BCYC
$295M
| $13.5M | 0.2% |
443,266
+5,538
| +1% | +$167K |
|
77
Texas Roadhouse
TXRH
$13B
| $12.7M | 0.19% |
+131,839
| New | +$13M |
|
|
STSA
78
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $11.2M | 0.16% |
1,583,889
+351,495
| +29% | +$1.9M |
|
|
RETA
79
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $11.1M | 0.16% |
+78,672
| New | +$8.88M |
|
80
Dine Brands
DIN
$463M
| $10.5M | 0.15% |
118,070
-103,541
| -47% | -$9.58M |
|
|
CANO
81
DELISTED
Cano Health, Inc.
CANO
| $9.94M | 0.15% |
+8,217
| New | +$11.1M |
|
|
JCIC
82
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
| $8.66M | 0.13% |
899,425
+13,305
| +2% | +$129K |
|
|
GAP
83
The Gap Inc
GAP
$7.4B
| $8.65M | 0.13% |
+257,176
| New | +$8.49M |
|
84
Marqeta
MQ
$1.84B
| $8.42M | 0.12% |
+75,000
| New | +$8.95M |
|
85
Etsy
ETSY
$7.94B
| $8.34M | 0.12% |
+40,506
| New | +$7.5M |
|
|
GLHA
86
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
| $7.83M | 0.11% |
+813,091
| New | +$7.85M |
|
87
Home Depot
HD
$347B
| $6.73M | 0.1% |
+21,119
| New | +$6.72M |
|
88
Dave & Buster's
PLAY
$362M
| $6.31M | 0.09% |
155,419
-178,448
| -53% | -$7.72M |
|
|
LOGC
89
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $6.31M | 0.09% |
1,420,452
+20,608
| +1% | +$105K |
|
90
TJX Companies
TJX
$171B
| $6.22M | 0.09% |
92,257
+8,708
| +10% | +$594K |
|
91
Designer Brands
DBI
$299M
| $5.61M | 0.08% |
339,028
+222,465
| +191% | +$3.92M |
|
92
Union Pacific
UNP
$179B
| $5.09M | 0.07% |
23,126
+3,171
| +16% | +$706K |
|
93
Delta Air Lines
DAL
$56.4B
| $4.58M | 0.07% |
105,957
-38,805
| -27% | -$1.8M |
|
94
dLocal
DLO
$4.13B
| $4.48M | 0.07% |
+85,336
| New | +$3.28M |
|
|
SLGC
95
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $4.4M | 0.06% |
+358,760
| New | +$4.4M |
|
96
Walmart Inc
WMT
$924B
| $4.18M | 0.06% |
88,881
+5,298
| +6% | +$247K |
|
|
MILE
97
DELISTED
Metromile, Inc. Common Stock
MILE
| $4M | 0.06% |
+436,810
| New | +$3.91M |
|
98
Finance of America Companies
FOA
$215M
| $3.81M | 0.06% |
+50,000
| New | +$4.84M |
|
99
Darden Restaurants
DRI
$23.1B
| $3.8M | 0.06% |
+26,037
| New | +$3.66M |
|
100
Ross Stores
ROST
$75B
| $3.45M | 0.05% |
27,807
+2,638
| +10% | +$329K |
|
Similar funds
LIP
JSSH
CIC
BSL
MWM
TCM
VAM
WAM
Samlyn Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Samlyn Capital held 211 positions worth $6.82B, down 5.9% from $7.25B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Samlyn Capital withdrew a net $1.08B in Q2 2021, closing 48 positions and reducing 53 holdings. Its most notable exit was Morgan Stanley, an estimated $174M position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Samlyn Capital opened a new position in Biogen worth $130M.
- Samlyn Capital's largest Q2 2021 buy was Biogen: 376,231 shares worth $130M.
- Samlyn Capital added most to Walt Disney in Q2 2021, an estimated $93.6M increase.
- Samlyn Capital's biggest Q2 2021 reduction was Athene Holding Ltd. Class A Common Shares, cutting an estimated $236M.
- Samlyn Capital fully exited Morgan Stanley in Q2 2021, selling an estimated $174M.
- Samlyn Capital's ten largest holdings make up 38% of its $6.82B portfolio in Q2 2021.
- Samlyn Capital opened 63 new positions and closed 48 in Q2 2021.
- Samlyn Capital's portfolio value fell 5.9% quarter-over-quarter to $6.82B.
Based on Samlyn Capital's 13F filing for Q2 2021, filed 16 Aug 2021.